DexCom's revised FY24 sales guidance in the Q2 earnings call led to a $18bn valuation reset. Read why I think DXCM stock is a ...

DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, ...

Dexcom announced today that its G6 continuous glucose monitor (CGM) is being worn by astronauts as part of the Polaris Dawn ...

New over-the-counter sensors, an Abbott-Medtronic partnership and Roche’s first CGM are among diabetes technology’s top stories so far in 2024. Check out MedTech Dive’s roundup of the latest news.

DexCom, Inc. (Nasdaq: DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, today announced the Dexcom G6 Continuous Glucose Monitoring (CGM) System is being ...

Little did I realize a few grapes could send my blood sugar soaring until I tried the first glucose monitor without a ...

Dexcom got on my radar back in 2020 when I wrote about the Dexcom 6 sensor. Back then, it was bigger and it had a shorter battery life. The march of Moore’s Law and other design updates has now ...

The U.S. FDA cleared Senseonic Holdings Inc.’s Eversense 365, the first continuous glucose monitor to last a full year with a single sensor rather than the 10 days to two weeks typical for wearable ...

DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time ... STELO IMPORTANT INFORMATION: Consult your healthcare provider before making any medication adjustments based on your sensor readings and ...

Dexcom's Stelo uses a wearable sensor, paired with an application on the user's smartphone or other smart device to continuously measure blood glucose levels. Advt The device is not for ...

Dexcom's Stelo uses a wearable sensor, paired with an application on the user's smartphone or other smart device to continuously measure blood glucose levels. The device is not for individuals ...